Furthermore, investigations into specific compounds, such as kaempferol and quercetin, suggest their role in modulating PPARG expression and interacting with AKT1, pointing towards potential treatment avenues for endometrial cancer and nonsegmental vitiligo [22, 23]. This evidence concerns the gene PPARG and endometrial cancer.